Scarica l'app Stockscreener
305.69
3.32%
9.82
Pre-mercato:
306.38
0.69
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$295.87
Aprire:
$296.465
Volume 24 ore:
2.52M
Relative Volume:
0.94
Capitalizzazione di mercato:
$164.37B
Reddito:
$34.13B
Utile/perdita netta:
$5.93B
Rapporto P/E:
27.89
EPS:
10.96
Flusso di cassa netto:
$10.92B
1 W Prestazione:
+4.51%
1M Prestazione:
+5.65%
6M Prestazione:
+11.79%
1 anno Prestazione:
-9.01%
Intervallo 1D:
$295.86
$306.80
Intervallo di 1 settimana:
$292.33
$306.80
Portata 52W:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
305.69 | 157.28B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
776.44 | 692.83B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
167.93 | 373.35B | 90.63B | 22.66B | 18.57B | 9.35 |
|
ABBV
Abbvie Inc
|
187.11 | 329.24B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
116.83 | 231.66B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
66.78 | 298.68B | 43.59B | 15.04B | 10.74B | 3.3766 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Balentine LLC - MarketBeat
Dow Leads as Merck, Amgen Gain: Stock Market Today - Kiplinger
Beacon Investment Advisory Services Inc. Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Price Target Raised to $305.00 - MarketBeat
KLP Kapitalforvaltning AS Buys 3,400 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s Blinatumomab Study: A Potential Game-Changer for Leukemia Treatment - TipRanks
Universal Beteiligungs und Servicegesellschaft mbH Trims Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PFG Advisors Has $5.47 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Gries Financial LLC Sells 7,176 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What analysts say about Amgen Inc. stockExceptional trading results - jammulinksnews.com
Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights - GlobeNewswire Inc.
Amgen Inc. Stock Analysis and ForecastRemarkably fast returns - Autocar Professional
Amgen Inc. (NASDAQ:AMGN) Stock Position Lowered by Morningstar Investment Services LLC - MarketBeat
SNS Financial Group LLC Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Stock Acquired Rep. Cliff Bentz - MarketBeat
Evergreen Wealth Management LLC Acquires 3,592 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Private Advisor Group LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Lobbying Update: $2,580,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitative
Amgen’s Promising Study on Advanced Gastric Cancer: What Investors Need to Know - TipRanks
Amgen’s Jyothis George named NodThera CMO - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Arrow Financial Corp - MarketBeat
Humira Biosimilar Market Gains Momentum Post-Patent Expiry & - openPR.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Peregrine Asset Advisers Inc. - MarketBeat
J.W. Cole Advisors Inc. Has $3.60 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. shares fall 1.03% premarket after Roche's mixed clinical trial results for COPD drug. - AInvest
Larson Financial Group LLC Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What drives Amgen Inc. stock priceUnprecedented market success - Autocar Professional
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Forum Financial Management LP - MarketBeat
Amgen Stock (AMGN) Opinions on Recent Price Declines and Technical Trends - Quiver Quantitative
Los Angeles Capital Management LLC Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Wealth Alliance LLC Acquires 999 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Souders Financial Advisors Sells 4,633 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Heritage Investors Management Corp Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Teachers Retirement System of The State of Kentucky Acquires 1,839 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Twin Capital Management Inc. Increases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Raised by OneAscent Financial Services LLC - MarketBeat
Elyxium Wealth LLC Invests $618,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Copperwynd Financial LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cullen Frost Bankers Inc. Purchases 4,162 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Montrusco Bolton Investments Inc. Has $210.72 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Romiplostim Study: A Potential Breakthrough in Chemotherapy-Induced Thrombocytopenia Treatment. - AInvest
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Commerzbank Aktiengesellschaft FI - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Verdence Capital Advisors LLC - MarketBeat
Parcion Private Wealth LLC Sells 1,188 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Concord Wealth Partners Has $3.09 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is Amgen Inc. a good long term investmentRapid market gains - jammulinksnews.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by St. Louis Trust Co - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Cut by Jennison Associates LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Edgestream Partners L.P. - MarketBeat
Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025 - Yahoo Finance
Amgen (AMGN) Declines More Than Market: Some Information for Investors - Yahoo Finance
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):